Title of article
Vascular Access Site Complications After Percutaneous Coronary Intervention With Abciximab in the Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) Trial
Author/Authors
Blankenship MD، نويسنده , , James C. and Hellkamp MS، نويسنده , , Anne S. and Aguirre MD، نويسنده , , Frank V. and Demko RN، نويسنده , , S.Lee and Topol MD، نويسنده , , Eric J. and Califf MD، نويسنده , , Robert M.، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 1998
Pages
5
From page
36
To page
40
Abstract
Thrombolytic therapy or intense anticoagulation during percutaneous transluminal coronary revascularization (PTCR) increases the risk of vascular access site complications. This study evaluated the association of abciximab, a glycoprotein IIb/IIIa recepto
Journal title
American Journal of Cardiology
Serial Year
1998
Journal title
American Journal of Cardiology
Record number
1886993
Link To Document